G937-2111 Screening compound: ethyl 1-ethyl-2,5-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate

G937-2111 Screening compound: ethyl 1-ethyl-2,5-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate
G937-2111 Screening compound: ethyl 1-ethyl-2,5-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound G937-2111
ethyl 1-ethyl-2,5-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G937-2111

Molecular Formula

C24H39N3O5S (C24 H39 N3 O5 S)

Compound Name

ethyl 1-ethyl-2,5-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate

IUPAC name

ethyl 1-ethyl-25-dimethyl-4-({3-[(4-methylcyclohexyl)carbamoyl]piperidin-1-yl}sulfonyl)-1H-pyrrole-3-carboxylate

SMILES

CCn(c(C)c1C(OCC)=O)c(C)c1S(N(CCC1)CC1C(NC1CCC(C)CC1)=O)(=O)=O

InChI

InChI=1S/C24H39N3O5S/c1-6-27-17(4)21(24(29)32-7-2)22(18(27)5)33(30,31)26-14-8-9-19(15-26)23(28)25-20-12-10-16(3)11-13-20/h16,19-20H,6-15H2,1-5H3,(H,25,28)/t16?,19-,20?/m0/s1

InChI Key

ZEVNOTGGXPETQQ-AJPWXKBRSA-N

MDL Number (MFCD)

MFCD15076183

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

481.66

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.431

Distribution Coefficient, logD

3.431

Water Solubility, LogSw

-3.74

Polar Surface Area

78.469

Acid Dissociation Constant (pKa)

14.42

Base Dissociation Constant (pKb)

1.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

75.00

G937-2111 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with G937-2111 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G937-2111?
Check Price and Availability of G937-2111, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G937-2111 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G937-2111
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G937-2111
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G937-2111 available by request